Sangamo Therapeutics (SGMO) Tops Q4 EPS by 8c
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
EPS Growth %: +25.0%
Financial Fact:
Research grants: 95K
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: +25.0%
Financial Fact:
Research grants: 95K
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Sangamo Therapeutics (NASDAQ: SGMO) reported Q4 EPS of ($0.26), $0.08 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $28 million versus the consensus estimate of $26.82 million.
For earnings history and earnings-related data on Sangamo Therapeutics (SGMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- Morgan Stanley upgrades CDW on stronger AI-driven server demand
- Worthington Enterprises raises dividend 5%, adds board member
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
